• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于重建手术的无穷尽移植替代物——全脐带组织中I类HLA分子的组织学特征

Histological Characterization of Class I HLA Molecules in Whole Umbilical Cord Tissue Towards an Inexhaustible Graft Alternative for Reconstructive Surgery.

作者信息

Yao Yue Ying, Lee Dennis K, Jarvi Stephanie, Farshadi Marjan, Sheng Minzhi, Mar Sara, Nevo Ori, Leong Hon S

机构信息

Department of Medical Biophysics, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5G 1L7, Canada.

Biological Sciences Platform, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.

出版信息

Bioengineering (Basel). 2023 Jan 12;10(1):110. doi: 10.3390/bioengineering10010110.

DOI:10.3390/bioengineering10010110
PMID:36671682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9855378/
Abstract

BACKGROUND

Limited graft availability is a constant clinical concern. Hence, the umbilical cord (UC) is an attractive alternative to autologous grafts. The UC is an inexhaustible tissue source, and its removal is harmless and part of standard of care after the birth of the baby. Minimal information exists regarding the immunological profile of a whole UC when it is considered to be used as a tissue graft. We aimed to characterize the localization and levels of class I human leukocyte antigens (HLAs) to understand the allogenicity of the UC. Additionally, HLA-E and HLA-G are putative immunosuppressive antigens that are abundant in placenta, but their profiles in UC whole tissue are unclear.

HYPOTHESIS

The UC as a whole expresses a relatively low but ubiquitous level of HLA-ABC and significant levels of HLA-G and HLA-E.

METHODS

Healthy patients with no known pregnancy-related complications were approached for informed consent. UCs at term and between 12 and 19 weeks were collected to compare HLA profiles by gestational age. Formalin-fixed paraffin-embedded tissues were sectioned to 5 µm and immunohistochemically stained with a pan-HLA-ABC, two HLA-G-specific, or an HLA-E-specific antibody.

RESULTS

HLA-ABC was consistently found present in UCs. HLA-ABC was most concentrated in the UC vessel walls and amniotic epithelium but more dispersed in the Wharton's Jelly. HLA-E had a similar localization pattern to HLA-ABC in whole UC tissues at both gestational ages, but its protein level was lower. HLA-G localization and intensity were poor in all UC tissues analyzed, but additional analyses by Western immunoblot and mass spectrometry revealed a low level of HLA-G in the UC.

CONCLUSION

The UC may address limitations of graft availability. Rather than the presence of HLA-G, the immunosuppressive properties of the UC are more likely due to the abundance of HLA-E and the interaction known to occur between HLA-E and HLA-ABC. The co-localization of HLA-E and HLA-ABC suggests that HLA-E is likely presenting HLA-ABC leader peptides to immune cells, which is known to have a primarily inhibitory effect.

摘要

背景

移植物供应有限一直是临床关注的问题。因此,脐带是自体移植物的一种有吸引力的替代物。脐带是一种取之不尽的组织来源,其采集无害,且是婴儿出生后标准护理的一部分。关于将整个脐带用作组织移植物时的免疫特征,现有信息极少。我们旨在确定I类人类白细胞抗原(HLA)的定位和水平,以了解脐带的同种异体反应性。此外,HLA-E和HLA-G是推测具有免疫抑制作用的抗原,在胎盘中含量丰富,但它们在脐带全组织中的特征尚不清楚。

假设

作为一个整体,脐带表达相对较低但普遍存在的HLA-ABC水平,以及显著水平的HLA-G和HLA-E。

方法

向无已知妊娠相关并发症的健康患者征求知情同意。收集足月及12至19周的脐带,以比较不同孕周的HLA特征。将福尔马林固定石蜡包埋组织切成5μm切片,并用泛HLA-ABC、两种HLA-G特异性或一种HLA-E特异性抗体进行免疫组织化学染色。

结果

在脐带中始终发现有HLA-ABC。HLA-ABC最集中于脐带血管壁和羊膜上皮,但在华通胶中分布更分散。在两个孕周的脐带全组织中,HLA-E的定位模式与HLA-ABC相似,但其蛋白水平较低。在所有分析的脐带组织中,HLA-G的定位和强度均较差,但通过Western免疫印迹和质谱进行的进一步分析显示脐带中存在低水平的HLA-G。

结论

脐带可能解决移植物供应的限制问题。脐带的免疫抑制特性更可能是由于HLA-E的丰富以及已知HLA-E与HLA-ABC之间发生的相互作用,而不是由于HLA-G的存在。HLA-E和HLA-ABC的共定位表明,HLA-E可能将HLA-ABC前导肽呈递给免疫细胞,已知这主要具有抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/6562da94c29f/bioengineering-10-00110-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/71ad0e78eb6a/bioengineering-10-00110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/5070a92e525f/bioengineering-10-00110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/ec6ccffda96f/bioengineering-10-00110-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/6864ed18de1c/bioengineering-10-00110-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/8053b474e1c1/bioengineering-10-00110-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/df3a55e04d77/bioengineering-10-00110-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/6562da94c29f/bioengineering-10-00110-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/71ad0e78eb6a/bioengineering-10-00110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/5070a92e525f/bioengineering-10-00110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/ec6ccffda96f/bioengineering-10-00110-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/6864ed18de1c/bioengineering-10-00110-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/8053b474e1c1/bioengineering-10-00110-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/df3a55e04d77/bioengineering-10-00110-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f575/9855378/6562da94c29f/bioengineering-10-00110-g007.jpg

相似文献

1
Histological Characterization of Class I HLA Molecules in Whole Umbilical Cord Tissue Towards an Inexhaustible Graft Alternative for Reconstructive Surgery.用于重建手术的无穷尽移植替代物——全脐带组织中I类HLA分子的组织学特征
Bioengineering (Basel). 2023 Jan 12;10(1):110. doi: 10.3390/bioengineering10010110.
2
Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.比较分析同一脐带不同部位来源的人脐带华通氏胶间充质干细胞。
Cell Tissue Res. 2018 Apr;372(1):51-65. doi: 10.1007/s00441-017-2699-4. Epub 2017 Dec 4.
3
MSCs can be differentially isolated from maternal, middle and fetal segments of the human umbilical cord.间充质干细胞可以从人脐带的母体段、中间段和胎儿段中进行差异性分离。
Cytotherapy. 2016 Dec;18(12):1493-1502. doi: 10.1016/j.jcyt.2016.08.003. Epub 2016 Oct 7.
4
An expression of IGF-binding proteins in normal and pre-eclamptic human umbilical cord serum and tissues.胰岛素样生长因子结合蛋白在正常及子痫前期孕妇脐带血清和组织中的表达。
Mol Cell Biochem. 2002 Aug;237(1-2):111-7. doi: 10.1023/a:1016599503834.
5
Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells.源自脐带华通氏胶的间充质基质细胞向肝细胞样细胞的分化。
Cytotherapy. 2009;11(5):548-58. doi: 10.1080/14653240903051533.
6
[Expression of Galectins in umbilical cord mesenchymal stem cells].[半乳糖凝集素在脐带间充质干细胞中的表达]
Beijing Da Xue Xue Bao Yi Xue Ban. 2013 Jun 18;45(3):452-7.
7
Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications.用于临床应用的脐带组织源间充质干细胞的分离与增殖
Cell Tissue Bank. 2016 Jun;17(2):289-302. doi: 10.1007/s10561-015-9541-6. Epub 2015 Dec 17.
8
Comparison of human amniotic fluid-derived and umbilical cord Wharton's Jelly-derived mesenchymal stromal cells: Characterization and myocardial differentiation capacity.人羊水来源和脐带华通氏胶来源间充质基质细胞的比较:特征和心肌分化能力。
J Geriatr Cardiol. 2012 Jun;9(2):166-71. doi: 10.3724/SP.J.1263.2011.12091.
9
Human leukocyte antigen HLA-C, HLA-G, HLA-F, and HLA-E placental profiles are altered in early severe preeclampsia and preterm birth with chorioamnionitis.人类白细胞抗原 HLA-C、HLA-G、HLA-F 和 HLA-E 的胎盘谱在早发性重度子痫前期和伴有绒毛膜羊膜炎的早产中发生改变。
Am J Obstet Gynecol. 2022 Oct;227(4):641.e1-641.e13. doi: 10.1016/j.ajog.2022.07.021. Epub 2022 Jul 19.
10
HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy.HLA-G 和 CD152 的表达水平鼓励使用脐带组织来源的间充质基质细胞作为免疫抑制治疗的替代方法。
Cells. 2022 Apr 14;11(8):1339. doi: 10.3390/cells11081339.

本文引用的文献

1
Hypospadias: A Comprehensive Review Including Its Embryology, Etiology and Surgical Techniques.尿道下裂:一项全面综述,涵盖其胚胎学、病因学及手术技术
Cureus. 2022 Jul 31;14(7):e27544. doi: 10.7759/cureus.27544. eCollection 2022 Jul.
2
NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-E.NKG2A 检查点抑制及其阻断在很大程度上取决于其配体 HLA-E 呈递的肽。
Immunology. 2022 Aug;166(4):507-521. doi: 10.1111/imm.13515. Epub 2022 Jun 6.
3
Novel Insights into the Stemness and Immune Privilege of Mesenchymal Stem Cells from Human Wharton Jelly by Single-Cell RNA Sequencing.
单细胞 RNA 测序揭示人牙髓间充质干细胞的干性和免疫特权的新见解。
Med Sci Monit. 2022 Feb 14;28:e934660. doi: 10.12659/MSM.934660.
4
Wound Healing by Allogeneic Transplantation of Specific Subpopulation From Human Umbilical Cord Mesenchymal Stem Cells.异体移植人脐带间充质干细胞特定亚群促进伤口愈合。
Cell Transplant. 2021 Jan-Dec;30:963689721993774. doi: 10.1177/0963689721993774.
5
Mechanical, compositional and morphological characterisation of the human male urethra for the development of a biomimetic tissue engineered urethral scaffold.用于开发仿生组织工程尿道支架的人类男性尿道的力学、成分和形态表征。
Biomaterials. 2021 Feb;269:120651. doi: 10.1016/j.biomaterials.2021.120651. Epub 2021 Jan 9.
6
One-year safety, healing and amputation rates of Wagner 3-4 diabetic foot ulcers treated with cryopreserved umbilical cord (TTAX01).采用冷冻脐带(TTAX01)治疗的 Wagner 3-4 型糖尿病足溃疡的 1 年安全性、愈合率和截肢率。
Wound Repair Regen. 2020 Jul;28(4):526-531. doi: 10.1111/wrr.12809. Epub 2020 May 9.
7
Tendon regeneration induced by umbilical cord graft in a rabbit tendon defect model.脐带移植在兔跟腱缺损模型中诱导的腱再生。
J Tissue Eng Regen Med. 2020 Aug;14(8):1009-1018. doi: 10.1002/term.3052. Epub 2020 Jun 22.
8
The unconventional role of HLA-E: The road less traveled.HLA-E 的非传统作用:少有人走的路。
Mol Immunol. 2020 Apr;120:101-112. doi: 10.1016/j.molimm.2020.02.011. Epub 2020 Feb 26.
9
Regulatory CD8 T cells that recognize Qa-1 expressed by CD4 T-helper cells inhibit rejection of heart allografts.调节性 CD8 T 细胞识别 CD4 T 辅助细胞表达的 Qa-1,抑制心脏同种异体移植物的排斥。
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6042-6046. doi: 10.1073/pnas.1918950117. Epub 2020 Feb 28.
10
Umbilical cord-derived Wharton's jelly for regenerative medicine applications.脐带衍生的华通氏胶在再生医学中的应用。
J Orthop Surg Res. 2020 Feb 13;15(1):49. doi: 10.1186/s13018-020-1553-7.